Lamitor DT 50 Tablet contains Lamotrigine 50mg, an anticonvulsant medication primarily used in the management of epilepsy and bipolar disorder. Lamotrigine acts by stabilizing neuronal membranes and inhibiting voltage-sensitive sodium channels, thereby reducing the release of excitatory neurotransmitters such as glutamate. This mechanism helps in controlling seizures and mood swings. Lamitor DT 50 is indicated for the treatment of partial seizures, generalized tonic-clonic seizures, and seizures associated with Lennox-Gastaut syndrome. Additionally, it is prescribed as a maintenance treatment for bipolar disorder to delay the occurrence of mood episodes. The tablet is designed as a dispersible formulation, facilitating ease of administration, especially in patients with swallowing difficulties. Lamitor DT 50 should be initiated at a low dose and titrated gradually to minimize the risk of serious skin rashes, including Stevens-Johnson syndrome. Common adverse effects may include dizziness, headache, blurred vision, and nausea. It is essential to monitor patients for hypersensitivity reactions and to adjust dosages in cases of hepatic or renal impairment. Lamitor DT 50 should be used under medical supervision, adhering strictly to prescribed dosing schedules to ensure optimal therapeutic outcomes and minimize potential risks.